Our Vision

Bringing light to the science of cognition research.

The mission of the LuMind Research Down Syndrome Foundation is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down Syndrome.

Our Approach  Learn More

How Your Donation Helps

Cognition research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective therapies to improve cognition and delay the onset of Alzheimer’s disease within the Ds community. Your gift is crucial to furthering these breakthroughs.

By the Numbers

Down syndrome in our community and the world.

US Statistics

250,000 - 400,000

The number persons with Down syndrome in the US

Worldwide Numbers

7,000,000

Estimated number of people with Down syndrome worldwide

Dollars per person

$9

The amount of research dollars per diagnosed person with Down syndrome

LuMind RDS News

Down Syndrome Organizations Give to Research

We are proud to be affiliated with those in the community who help individuals with Down syndrome (Ds) and their families make sense of early childhood interventions, individualized education plans (IEPs), strategies for inclusion, and most importantly, create a welcoming environment that celebrates the abilities in people with Ds and connects them to one another. …

Read More

LuMind RDS Research Partner Jamie Edgin Wins $2.9 Million Grant

This holiday season, LuMind Research Down Syndrome is celebrating Dr. Jamie Edgin and her newly awarded five-year, $2.9 million grant from the National Institute of Child Health and Development (NICHD) to expand research on developing the Arizona Cognitive Testing Battery. Dr. Jamie Edgin is an assistant professor of psychology and serves as the associate head …

Read More

President Obama Signs 21st Century Cures Bill into Law, Offering New Hope

In November, LuMind Research Down Syndrome Foundation joined with the National Health Council as a co-signatory on a post-election letter to Congress, urging lawmakers to move a legislation forward that hopes to speed the development of treatments and cures. Of the 217 organizations undersigning the letter of support, representing a widely diverse community of patients and family caregivers, LuMind …

Read More

What people are saying about us.

“I never thought I would be in a position to say, ‘We are going to take therapies forward to directly treat Down syndrome.’ Now I think that is the case. We really are in the early stages of a revolution in understanding the basis for many of the features that occur in Down syndrome.”

Dr. Roger Reeves, Johns Hopkins